Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD
2015; Springer Science+Business Media; Volume: 123; Issue: 3 Linguagem: Inglês
10.1007/s00702-015-1486-1
ISSN1435-1463
AutoresEmily Feneberg, Petra Steinacker, Alexander E. Volk, Jochen H. Weishaupt, M. Axel Wollmer, Adam L. Boxer, Hayrettin Tumani, Albert C. Ludolph, Markus Otto,
Tópico(s)Alzheimer's disease research and treatments
Referência(s)